Inactivity of nitric oxide synthase gene in the atherosclerotic human carotid artery

Basic Research in Cardiology

Volumn 102, Issue 4, 2007, Pages 308-317

  Tanner, F C ^a,h   van der Loo, B ^a,h   Shaw, S ^b   Greutert, H ^a   Bachschmid, M M ^c   Rozenberg, I ^a   Blau, N ^d   Siebenmann, R ^e   Schmidli, J ^f   Meyer, P ^g   Luscher T F ^a,h  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF KONSTANZ   (Germany)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e HerzZentrum Hirslanden Zurich   (Switzerland)

^f BERN UNIVERSITY HOSPITAL   (Switzerland)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

^h UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Adenoviral vector; Atherosclerosis; Endothelium; Gene therapy; Nitric oxide synthase

Indexed keywords

ACETYLSALICYLIC ACID; ADENOVIRUS VECTOR; ARGININE; CATALASE; FLAVINE ADENINE NUCLEOTIDE; FLAVINE MONONUCLEOTIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE SYNTHASE; NITRITE; PORPHYRIN DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SEPIAPTERIN; SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE MACROGOL; TETRAHYDROBIOPTERIN;

ADULT; AGED; AORTA; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDARTERECTOMY; ENZYME ACTIVITY; ENZYME INACTIVATION; EX VIVO GENE TRANSFER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNAL MAMMARY ARTERY; MALE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ADENOVIRIDAE; AGED; ANIMALS; AORTA; ATHEROSCLEROSIS; CAROTID ARTERIES; CELL LINE; FEMALE; GENETIC VECTORS; HUMANS; MALE; MAMMARY ARTERIES; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RATS; SUPEROXIDES; TIME FACTORS; TISSUE CULTURE TECHNIQUES; TRANSDUCTION, GENETIC;

EID: 34250309565     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-007-0650-7     Document Type: Article

References (32)

1. Alcorn JL, Gao E, Chen Q, Smith ME,Gerard RD, Mendelson CR (1993) Genomic elements involved in transcriptional regulation of the rabbit surfactant protein-A gene. Mol Endocrinol 7:1072-1085
2. Barton M, Vos I, Shaw S, Boer P, d'Uscio LV, Gröne HJ, Rabelink TJ, Lattmann T, Moreau P, Luscher TF (2000) Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: Mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and glomerulosclerosis. J Am Soc Nephrol 11:835-846
3. Berendji-Grun D, Kolb-Bachofen V, Kroncke KD (2001) Nitric oxide inhibits endothelial IL-1(beta)-induced ICAM-1 gene expression at the transcriptional level decreasing Sp1 and AP-1 activity. Mol Med 7:748-754
4. Cannon RO (1998) Role of nitric oxidein cardiovascular disease: Focus on the endothelium. Clinical Chemistry 44:1809-1819
5. Chen AF, Jiang SW, Crotty TB, Tsutsui M, Smith LA, O'Brien T, Katusic ZS (1997) Effects of in vivo adventitial expressionof recombinant endothelialnitric oxide synthase gene in cerebralarteries. Proc Natl Acad Sci USA 94:12568-12573
6. Cooney R, Hynes SO, Duffy AM, SharifF, O'Brien T (2006) Adenoviral-mediated gene transfer of nitric oxide synthase isoforms and vascular cell proliferation.J Vasc Res 43:462-472
7. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP (1992) L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 90:1248-1253
8. d'Uscio LV, Baker TA, Mantilla CB, Smith L, Weiler D, Sieck GC, Katusic ZS (2001) Mechanism of endothelial dysfunctionin apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21:1017-1022
9. Förstermann U (2006) Janus-faced role of endothelial NO synthase in vascular disease: Uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol Chem 387:1521-1533
10. Fukushima T, Nixon JC (1980) Analysis of reduced forms of biopterin in biological tissues and fluids. Anal Biochem 102:176-188
11. Lauer T, Kleinbongard P, Preik M, Rauch BH, Deussen A, Feelisch M, Strauer B, Kelm M (2003) Direct biochemical evidence for eNOS stimulation by bradykinin in the human forearm vasculature. Basic Res Cardiol 98:84-89
12. Lüscher TF, Vanhoutte PM (1990) The Endothelium: Modulator of Cardiovascular Function. CRC Press, Boca Raton
13. Meyer P, Champion C, Schlötzer-Schrehardt U, Flammer J, Haefliger IO (1999) Localisation of nitric oxide isoforms in porcine ocular tissues. Current Eye Research 18:375-380
14. Mittereder N, March KL, Trapnell BC(1996) Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virology 70:7498-7509
15. Mujynya-Ludunge K, Viswambharan H, Driscoll R, Ming X-F, von Segesser LK, Kappenberger L, Yang Z, Vassalli G(2005) Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotidarteries in apolipoprotein E-deficient mice. Basic Res Cardiol 100:102-111
16. Nelson SH, Steinsland OS, Wang Y, Yallampalli C, Dong YL, Sanchez JM (2000) Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy. Circ Res 87:406-411
17. Oemar BS, Tschudi MR, Godoy N, Brovkovith V, Malinski T, Luscher TF (1998) Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 97:2494-2498
18. Ohara Y, Peterson TE, Harrison DG (1993) Hypercholesterolemia increases endothelial superoxide anion production.J Clin Invest 91:2546-2551
19. Ohno T, Gordon D, San H, Pompilij VJ, Imperiale MJ, Nabel GJ, Nabel EG (1994) Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 265:781-784
20. Rekhter MD, Simari RD, Work CW,Nabel GJ, Nabel EG, Gordon D (1998) Gene transfer into normal and atherosclerotic human blood vessels. Circ Res 82:1243-1252
21. Ross R (1986) The pathogenesis of atherosclerosis - an update. N Engl J Med 314:488-500
22. Stroes ESG, Kastelein JJ, Cosentino F, Erkelens W, Wever R, Koomans H, Luscher T, Rabelink T (1997) Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 99:41-46
23. Tanner FC, Carr DP, Nabel GJ, Nabel EG (1997) Transfection of human endothelial cells. Cardiovasc Res 35:522-528
24. Tanner FC, Yang Z, Duckers E, GordonD, Nabel GJ, Nabel EG (1998) Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 82:396-403
25. Tanner FC, Meyer P, Greutert H, Champion C, Nabel EG, Luscher TF (2000) Nitric oxide modulates expression of cell cycle regulatory proteins: A cytostatic strategy for inhibiting human vascular smooth muscle cell proliferation. Circulation 101:1982-1989
26. Tanner FC, Largiadeèr T, Greutert H,Yang Z, Luscher TF (2004) Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein. J Thorac Cardiovasc Surg 127:20-26
27. Tarpey MM, White CR, Suarez E,Richardson G, Radi R, Freeman BA (1999) Chemiluminescent detection of oxidants in vascular tissue. Lucigenin but not coelenterazine enhances superoxide formation. Circ Res 84:1203-1211
28. Tschudi MR, Barton M, Bersinger NA,Moreau P, Cosentino F, Noll G, MalinskiT, Luscher TF (1996) Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest 98:899-905
29. Varenne O, Pislaru S, Gillijns H, van PeltN, Gerard RD, Zoldhelyi P, van de WerfF, Collen D, Hanssens SP (1998) Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation 98:919-926
30. von der Thüsen JH, Fekkes ML, Passier R, von Zonnefeld AJ, Mainfroid V, van Berkel TJC, Biessen EAL (2004) Adenoviral transfer of endothelial nitric oxide synthase attenuates lesion formation in a novel murine model of postangioplasty restenosis. ArteriosclerThromb Vasc Biol 24:357-362
31. Wever RMF, Luscher TF, Cosentino F, Rabelink T (1998) Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 97:108-112
32. Yang Z, Simari RD, Tanner FC, Stephan D, Nabel GJ, Nabel EG (1996) Gene transfer approaches to the regulation of vascular cell proliferation. Semin Intervent Cardiol 1:181-184